Companies operating in the pharmaceutical, biotechnology, medical device, and broader life sciences industries face legal and regulatory challenges at nearly every stage of the product lifecycle. Product development, manufacturing, commercialization, supply chain relationships, promotional strategy, compliance obligations, and evolving regulatory expectations frequently intersect to shape how health products are brought to market and sustained commercially.
Morningstar Law Group advises pharmaceutical, biotechnology, medical device, healthcare, and other life sciences companies on the legal, regulatory, operational, and transactional issues that arise throughout the development and commercialization process. The practice combines FDA regulatory experience with a deep understanding of how pharmaceutical and life sciences companies operate, grow, structure commercial relationships, manage compliance obligations, and navigate increasingly complex regulatory environments.
The team regularly advises clients on FDA advertising and promotion, commercialization strategy, manufacturing and supply chain relationships, clinical and commercial agreements, health product compliance matters, internal investigations, and operational issues tied to product launch and growth.
Morningstar’s FDA and health product regulatory attorneys counsel clients on compliance with laws and regulations administered and enforced by agencies including the FDA, FTC, HHS-OIG, and DOJ, and regularly advise on issues involving health product marketing and advertising, the Anti-Kickback Statute compliance, the False Claims Act, Sunshine Act/Open Payments reporting, product sampling, and broader compliance program development.
Many of the firm’s attorneys bring substantial in-house experience within pharmaceutical, biotechnology, health product, and life sciences companies, including leadership roles involving legal operations, compliance, commercialization, and strategic growth. Select members of the team have served in senior in-house legal and compliance roles within pharmaceutical, biotechnology, and health product companies, providing clients with practical guidance informed by firsthand industry experience. That operational perspective allows our lawyers to provide business-oriented guidance grounded not only in regulatory requirements but also in the day-to-day realities of how life sciences companies operate, scale, and manage compliance risk across complex and evolving regulatory environments.
Morningstar attorneys also support clients in transactional matters involving licensing, development, manufacturing, distribution, commercialization, and strategic business relationships across the life sciences ecosystem.
Organizations We Serve
Morningstar’s FDA and health product regulatory attorneys advise clients across a broad range of life sciences, health product, and regulated-product companies, including:
- Pharmaceutical and specialty pharmaceutical
- Biotechnology and life sciences
- Medical device and diagnostics
- Life sciences companies
- Digital health and health technology
- Contract development and manufacturing (CDMO)
- Clinical research and contract research organizations (CROs)
- Generics and biosimilars
- Consumer health and wellness
- Research and development organizations
- Manufacturing and supply chain operations
- Venture-backed and emerging growth life sciences companies
